SYNRIBO (OMACETAXINE MEPESUCCINATE) — FDA Approval NDA203585 (TEVA PHARMS INTL)
SYNRIBO (OMACETAXINE MEPESUCCINATE) — FDA Approval NDA203585 (TEVA PHARMS INTL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SYNRIBO; Active ingredients: OMACETAXINE MEPESUCCINATE; Application number: NDA203585.
| Brand name | SYNRIBO |
|---|---|
| Active ingredients | OMACETAXINE MEPESUCCINATE |
| Application number | NDA203585 |
| Sponsor | TEVA PHARMS INTL |
| Dosage form | POWDER |
| Route | SUBCUTANEOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20121026 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →